Specific Modified Exercise Program for Patients Having Chronic Asthma

May 19, 2024 updated by: Riphah International University

Effects of Moderate Intensity Interval Training and Sprint Interval Training on Patients Having Chronic Asthma.

To compare the effects of moderate intensity interval training and sprint interval training on patients having chronic asthma.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Chronic asthma is a complex heterogeneous disease characterized by multiple aggravating factors. Asthma is treated with two types of medicines , long term medicines and quick relieve medicine. Although the relationship between asthma and the effects of HIIT/SIT were studied in the literature, there was not one comparing the results of these aforementioned studies. The purpose of this study is to find the effects of moderate intensity interval training and sprint interval training on pat determine effects of group wise physical activity on asthma related quality of life. To determine the effects of group wise physical activity on cardiorespiratory endurance

Study Type

Interventional

Enrollment (Actual)

78

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Federal Capital
      • Islamabad, Federal Capital, Pakistan, 46000
        • Abasyn University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients having chronic asthma
  • Age between 15-25 years.
  • Participants having no dyspnea at rest .
  • Participants scoring 13 or less on borg scale
  • Exclusion Criteria
  • History of co-morbidities.
  • History of recent fractures.
  • Participants scoring greater than 13 on BORG scale

Exclusion Criteria:

  • Exercise induced asthma (evaluated through BRUCE protocol).
  • Individuals with co-morbidities related to any neurological, cardiovascular, psychological and musculoskeletal disorders .
  • Patients score falling 15 or more on Borg scale.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Moderate Intensity Interval Training
These participants will perform moderate intensity interval training. The intervention will be applied thrice a week. Moderate intensity interval training in which they do stair climbing 3 times a week And for every 1 interval I will ask them to take rest for 3 minutes.
Other: Moderate Intensity Interval Training
Participants in this group will perform moderate intensity interval training in which they will perform stair climbing 3 times a week and for every 1 interval I will ask them to take rest for 3 minutes.
Experimental: Sprint Interval Training

These participants will perform sprint interval training and frequency will be 3 days a week.

The participants will perform sprint interval training in which they will do stair climbing 3 times a week with a fast pace.
Other: Sprint Interval Training
sprint interval training in which they will do stair climbing 3 times a week with a fast pace.
Other: pharmacological treatment
They will be on pharmacological treatment as prescribed by their pulmonologist.
Other: pharmacological treatment
They will be on pharmacological treatment as prescribed by their pulmonologist.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of change in the Inspiratory Capacity
Time Frame: Baseline, 8th week and then 16th week
It will measured using an incentive spirometer
Baseline, 8th week and then 16th week
Assessment of change in the Pulmonary Function
Time Frame: Baseline, 8th week and then 16th week
Electronic spirometer will be used to measure all the parameters of pulmonary function.
Baseline, 8th week and then 16th week
Assessment of change in the Oxygen saturation
Time Frame: Baseline, 8th week and then 16th week
Measured using pulse oximeter before, during and after the intervention.
Baseline, 8th week and then 16th week
Assessment of change in the Rate of perceived exertion / dyspnea
Time Frame: Baseline, 8th week and then 16th week
measured through borg scale during the assigned intervention
Baseline, 8th week and then 16th week
Assessment of change in the cardiovascular endurance
Time Frame: Baseline, 8th week and then 16th week
PACER test for cardiovascular endurance test
Baseline, 8th week and then 16th week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Riphah International University

Investigators

  • Principal Investigator: Malik Muhammad Ali Awan, MSPT, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2023

Primary Completion (Actual)

January 1, 2024

Study Completion (Actual)

January 1, 2024

Study Registration Dates

First Submitted

May 4, 2023

First Submitted That Met QC Criteria

December 26, 2023

First Posted (Actual)

January 9, 2024

Study Record Updates

Last Update Posted (Actual)

May 21, 2024

Last Update Submitted That Met QC Criteria

May 19, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REC/MS-PT/01379

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Asthma

Clinical Trials on Moderate Intensity Interval Training

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe